Contract Manufacturing

Thermo Fisher to invest $475m into biopharma in 2020

25-Mar-2020 By Ben Hargreaves

Continuing a trend among larger CDMOs, Thermo Fisher reveals scale of investment into biopharma business and further focus on cell and gene therapy.

ProBioGen, Immunogenesis in cell line development agreement

24-Mar-2020 By Vassia Barba

Immunogenesis is tapping into ProBioGen’s manufacturing capabilities for its immuno-oncology lead candidate, as the potential treatment enters the clinic.

Pharma events update: rescheduled, canceled, online

18-Mar-2020 By Jenni Spinner

This list includes the industry events that have been postponed or moved because of the coronavirus pandemic.

Fujifilm Diosynth to create biocampus in the UK

18-Mar-2020 By Vassia Barba

Fujifilm Diosynth announced plans to build a research center in the UK to answer growing demand in services for biologics, vaccines, and gene therapies development.

AR company offers coronavirus-safe collaboration kits

17-Mar-2020 By Jenni Spinner

Apprentice is sending sets of technology tools to pharmaceutical research and manufacturing facilities, including its Tandem AR collaboration platform.

Altasciences acquires Alliance Contract Pharma

12-Mar-2020 By Jenni Spinner

The contract research organization has purchased Alliance Contract Pharma, a small-molecule contract manufacturing and analytical firm.

Formulation method improves bioavailability of poorly soluble molecules

09-Mar-2020 By Vassia Barba

Orion to benefit from Nanoform’s formulation technology, which is able to improve bioavailability and solubility of early-stage compounds.

WuXi in deal to develop Vir’s antibody against coronavirus

27-Feb-2020 By Vassia Barba

Vir Biotechnology turns to WuXi to support development and commercialization of an antibody-based potential treatment for the coronavirus.

Frontage continues build-out to meet late-stage developers demand

27-Feb-2020 By Vassia Barba

Frontage has announced completion of its Pennsylvania site expansion to boost its offering of bioanalytical services for late-stage cell and gene therapies developers.

BIA Separations in deal to expand virus purification offering

20-Feb-2020 By Vassia Barba

In its latest deal, BIA Separations brings to market an elution method developed by the University of Zagreb, which helps preserve viruses’ integrity, infectivity, and potency.

LakePharma and NJ Bio partner on ‘one-stop’ ADC manufacturing service

19-Feb-2020 By Vassia Barba

Antibody-focused service providers merge their offerings to create a ‘seamless workflow’ on antibody-drug conjugates to help save developers’ time and costs.

Univercells expands its offering to meet ‘fast-growing’ gene therapy demand

19-Feb-2020 By Vassia Barba

Funding from Gamma supports the development of Univercells’ biomanufacturing platform and bioreactors, with the latter looking to expand into the fast-growing gene therapy segment.